173 related articles for article (PubMed ID: 15237387)
1. Electrostatic surface potential calculation on several new halogenated benzimidazole-like dopaminergic ligands.
Sukalović V; Andrić D; Roglić G; Kostić-Rajaccić S; Soskić V
Arch Pharm (Weinheim); 2004 Jul; 337(7):376-82. PubMed ID: 15237387
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of N-n-propyl-N-(2-arylethyl)-5-(1H-benzimidazol-2-thione)-eth ylamines and related compounds as potential dopaminergic ligands.
Soskic V; Dukić S; Dragović D; Joksimović J
Arzneimittelforschung; 1996 Aug; 46(8):741-6. PubMed ID: 9125270
[TBL] [Abstract][Full Text] [Related]
3. New substituted 2-methylthiomethyl- and 2-methylsulphinylmethylenebenzimidazoles with D2/5-HT1A activity.
Kostić-Rajacić S; Soskić V; Joksimović J
Pharmazie; 1998 Jul; 53(7):438-41. PubMed ID: 9699220
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of N,N-di-n-propyl-5,6,7,8-tetrahydro-1 H-benz[f]benzimidazol-6-yl-amine and related congeners as dopaminergic ligands.
Dragović D; Soskić V; Joksimović J
Pharmazie; 1995 Oct; 50(10):678-80. PubMed ID: 7501691
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, dopamine D2 receptor binding studies and docking analysis of 5-[3-(4-arylpiperazin-1-yl)propyl]-1H-benzimidazole, 5-[2-(4-arylpiperazin-1-yl)ethoxy]-1H-benzimidazole and their analogs.
Sukalović V; Andrić D; Roglić G; Kostić-Rajacić S; Schrattenholz A; Soskić V
Eur J Med Chem; 2005 May; 40(5):481-93. PubMed ID: 15893022
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and properties of several heterocyclic dopaminergic ligands.
Kostić S; Soskić V; Joksimović J
Arzneimittelforschung; 1994 Jun; 44(6):697-702. PubMed ID: 7914413
[TBL] [Abstract][Full Text] [Related]
7. Modeling of the D2 dopamine receptor arylpiperazine binding site for 1-[2-[5-(1H-benzimidazole-2-thione)]ethyl]-4-arylpiperazines.
Sukalović V; Zlatović M; Andrić D; Roglić G; Kostić-Rajaccić S; Soskić V
Arch Pharm (Weinheim); 2004 Sep; 337(9):502-12. PubMed ID: 15362123
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and binding properties of several new dopaminergic ligands.
Tuce Z; Soskić V; Joksimović J
Drug Des Discov; 1994 Jun; 11(4):251-8. PubMed ID: 7727678
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and dopaminergic features of six novel 3-arylpiperidines.
Kostic-Rajacic A; Soskic V; Joksimovic J
Boll Chim Farm; 1998 Nov; 137(10):417-21. PubMed ID: 10025971
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, binding properties and receptor docking of 4-halo-6-[2-(4-arylpiperazin-1-yl)ethyl]-1H-benzimidazoles, mixed ligands of D2 and 5-HT1A receptors.
Andrić D; Roglić G; Sukalović V; Soskić V; Kostić-Rajacić S
Eur J Med Chem; 2008 Aug; 43(8):1696-705. PubMed ID: 18006194
[TBL] [Abstract][Full Text] [Related]
11. Introduction of a methyl group in alpha- or beta-position of 1-heteroarylethyl-4-phenylpiperazines affects their dopaminergic/serotonergic properties.
Roglic G; Andric D; Kostic-Rajacic S; Dukic S; Soskic V
Arch Pharm (Weinheim); 2001 Dec; 334(12):375-80. PubMed ID: 11852532
[TBL] [Abstract][Full Text] [Related]
12. D2 dopaminergic and 5-HT1A serotonergic activity of 2-(1-naphthyl)ethyl- and 2-(2-naphthyl)ethyl amines.
Šukalović V; Roglić G; Husinec S; Kostić-Rajaćić S; Andrić D; Šoškić V
Arch Pharm (Weinheim); 2003 Nov; 336(11):514-22. PubMed ID: 14639744
[TBL] [Abstract][Full Text] [Related]
13. N-n-Propyl-substituted 3-(dimethylphenyl)piperidines display novel discriminative properties between dopamine receptor subtypes: synthesis and receptor binding studies.
Cervetto L; Demontis GC; Giannaccini G; Longoni B; Macchia B; Macchia M; Martinelli A; Orlandini E
J Med Chem; 1998 Dec; 41(25):4933-8. PubMed ID: 9836610
[TBL] [Abstract][Full Text] [Related]
14. Phenylpiperazinylmethylheterocycle derivatives: synthesis and dopamine receptor binding profiles.
Abadi AH
Arch Pharm (Weinheim); 2004 Jul; 337(7):383-90. PubMed ID: 15237388
[TBL] [Abstract][Full Text] [Related]
15. Investigation of mixed D2/5-HT1A activity of N-heteroarylmethyl-N-phenylpiperazines, N-heteroarylethyl-N-phenylpiperazines and N-heteroarylpropyl-N-phenylpiperazines.
Roglić G; Dukić-Stefanović S; Andrić D; Kostić-Rajacić S; Soskić V
Pharmazie; 2001 Oct; 56(10):803-7. PubMed ID: 11683128
[TBL] [Abstract][Full Text] [Related]
16. Mixed dopaminergic/serotonergic properties of several 2-substituted 4-[2-(5-benzimidazole)ethyl]-1-arylpiperazines.
Kostic-Rajacic S; Soskic V; Joksimovic J
Arch Pharm (Weinheim); 1998 Jan; 331(1):22-6. PubMed ID: 9507698
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship of dopaminergic halogenated 1-benzyl-tetrahydroisoquinoline derivatives.
El Aouad N; Berenguer I; Romero V; Marín P; Serrano A; Andujar S; Suvire F; Bermejo A; Ivorra MD; Enriz RD; Cabedo N; Cortes D
Eur J Med Chem; 2009 Nov; 44(11):4616-21. PubMed ID: 19628309
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and dopaminergic properties of 3- and 4-substituted 1-[2-[5-(1H-benzimidazole-2-thione)]ethyl]piperidines and related compounds.
Dukic S; Kostic-Rajacic S; Soskic V; Joksimovic J
Arch Pharm (Weinheim); 1997; 330(1-2):25-8. PubMed ID: 9112811
[TBL] [Abstract][Full Text] [Related]
19. New N-n-propyl-substituted 3-aryl- and 3-cyclohexylpiperidines as partial agonists at the D4 dopamine receptor.
Macchia M; Cervetto L; Demontis GC; Longoni B; Minutolo F; Orlandini E; Ortore G; Papi C; Sbrana A; Macchia B
J Med Chem; 2003 Jan; 46(1):161-8. PubMed ID: 12502370
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydroisoquinolines as dopaminergic ligands: 1-Butyl-7-chloro-6-hydroxy-tetrahydroisoquinoline, a new compound with antidepressant-like activity in mice.
Berenguer I; El Aouad N; Andujar S; Romero V; Suvire F; Freret T; Bermejo A; Ivorra MD; Enriz RD; Boulouard M; Cabedo N; Cortes D
Bioorg Med Chem; 2009 Jul; 17(14):4968-80. PubMed ID: 19540762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
